Moderna
MRNA
#1333
Rank
S$17.71 B
Marketcap
$45.81
Share price
-2.03%
Change (1 day)
-68.86%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -S$3.16 Billion

According to Moderna 's latest financial reports the company's current earnings are S$5.05 Billion. In 2023 the company made an earning of -S$5.22 Billion a decrease over its 2022 earnings that were of S$12.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$3.16 Billion-39.49%
2023 -S$5.22 Billion-140.65%
2022 S$12.82 B-27.81%
2021 S$17.76 B-1911.15%
2020 -S$0.99 Billion44.7%
2019 -S$0.68 Billion28.63%
2018 -S$0.53 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$55.26 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$19.99 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$55.78 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.32 Billion-89.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.21 B-685.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.81 Billion-74.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.29 B-848.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA